Switzerland· 69232001
Veoza 45 mg, Filmtabletten
A fezolinetant product, registered in Switzerland by Astellas Pharma AG and dispensed under Swissmedic category B. The same ATC class is registered in 14 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Fezolinetant is registered in 14 of 19 countries.
Countries holding a registration under ATC G02CX06 (fezolinetant), each read from that country’s own register.
- This record: Switzerland
- 9 of them publish a price we can compare per daily dose
Fezolinetant · ATC G02CX06
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of fezolinetant costs, country by country.
Normalised to the WHO defined daily dose (45 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Fezolinetant · price per daily dose (45 mg)
USD · FX 28 Sept 2026
- ES Spain$3.02
The record
At a glance
- Manufacturer
- Astellas Pharma AG
- Country
- Switzerland (CH)
- ATC code
- G02CX06
- ATC class
- Fezolinetant
- Defined daily dose
- 45 mg, O
- Swissmedic category
- B
- Reimbursed
- No
- Last checked
- June 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under G02CX06
Fezolinetant, as other registers publish it.
- NorwayVeozaAstellas Pharma Europe BV
- PolandVeozaAstellas Pharma Europe B.V.
- IcelandVeozaAstellas Pharma Europe B.V.
- DenmarkVeozaAstellas Pharma Europe B.V.
- FinlandVeozaAstellas Pharma Europe B.V.
- CzechiaVEOZAAstellas Pharma Europe B.V., Leiden
- CzechiaVEOZAAstellas Pharma Europe B.V., Leiden
- CzechiaVEOZAAstellas Pharma Europe B.V., Leiden
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e743ff7e-4ebb-4a90-945f-af4a15a66f18 GET /v1/drugs/e743ff7e-4ebb-4a90-945f-af4a15a66f18?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Synthetika"
}See everything about fezolinetant.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.